疑难病杂志2013，Vol.12Issue(1)：2-4,3.DOI:10.3969/j.issn.1671-6450.2013.01.001
静脉注射胺碘酮与普罗帕酮治疗阵发性室上性心动过速疗效的Meta分析
A meta-analysis of amiodarone and propafenone treatment of supraventricular tachycardia
摘要
Abstract
Objective To evaluate the efficacy and safety of intravenous amiodarone and propafenone in treating par-oxysmal supraventricular tachycardia with the meta analysis. Methods Randomized controlled trials ( RCT ) included written in Chinese and English concerned using amiodarone and propafenone in treatment of paroxysmal supraventricular tachycardia were collected from 1999 to 2012 in a meta-analysis. The RevMan 5. 1 software of Cochrane Coordination Net was used for sta-tistical analysis. Results The therapy of amiodarone group and propafenone group in the treatment of paroxysmal supraventric-ular tachycardia effect analysis were: integrated test results was( OR = 1.45, 95% CIO.83 -2.51, P > 0. 05 ). The funnel plot analysis showed no significant bias. The adverse reaction analysis of amiodarone group and propafenone group therapy in the treatment of paroxysmal supraventricular tachycardia as follows: integrated test results was( OR =0.47, 95% CI 0. 29～ 0.77, P >0. 05 ). The funnel plot analysis showed no significant bias. Conclusion The amiodarone group and propafenone group therapy in the treatment of paroxysmal supraventricular tachycardia were showed no obvious differences. The incidence of adverse reactions of the amiodarone were lower than the propafenone.关键词
胺碘酮/普罗帕酮/心动过速,室上性,阵发性/Meta分析Key words
Amiodarone/Propafenone/Supraventricular tachycardia,paroxysmal/Meta-analysis引用本文复制引用
王少波,梁锦军,黄从新..静脉注射胺碘酮与普罗帕酮治疗阵发性室上性心动过速疗效的Meta分析[J].疑难病杂志,2013,12(1):2-4,3.
